These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 33137011)
1. Management of Trichomoniasis in the Setting of 5-Nitroimidazole Hypersensitivity. Van Gerwen OT; Camino AF; Bourla LN; Legendre D; Muzny CA Sex Transm Dis; 2021 Aug; 48(8):e111-e115. PubMed ID: 33137011 [TBL] [Abstract][Full Text] [Related]
2. Secnidazole: a treatment for trichomoniasis in adolescents and adults. Muzny CA; Van Gerwen OT; Legendre D Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1067-1076. PubMed ID: 35642509 [TBL] [Abstract][Full Text] [Related]
3. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Helms DJ; Mosure DJ; Secor WE; Workowski KA Am J Obstet Gynecol; 2008 Apr; 198(4):370.e1-7. PubMed ID: 18221927 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment with secnidazole for trichomoniasis in the setting of metronidazole hypersensitivity. Kufel WD; Asiago-Reddy EA; Parsels KA; Sanyal S; Coyne JL Int J STD AIDS; 2021 Nov; 32(13):1271-1273. PubMed ID: 34392726 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid. Muzny C; Barnes A; Mena L Sex Health; 2012 Sep; 9(4):389-91. PubMed ID: 22877600 [TBL] [Abstract][Full Text] [Related]
6. The antimicrobial effect of boric acid on Trichomonas vaginalis. Brittingham A; Wilson WA Sex Transm Dis; 2014 Dec; 41(12):718-22. PubMed ID: 25581807 [TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of Persistent 5-Nitroimidazole-Resistant Trichomoniasis With an Extended Course of Oral Secnidazole Plus Intravaginal Boric Acid. McNeil CJ; Williamson JC; Muzny CA Sex Transm Dis; 2023 Apr; 50(4):243-246. PubMed ID: 36730040 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of trichomoniasis with tinidazole following desensitization in a patient allergic to metronidazole. Biagi M; Slipke W; Smalley A; Tsaras G Int J STD AIDS; 2021 Jan; 32(1):89-91. PubMed ID: 33121364 [TBL] [Abstract][Full Text] [Related]
14. Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis. Rossignol JF; Maisonneuve H; Cho YW Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):63-72. PubMed ID: 6698665 [TBL] [Abstract][Full Text] [Related]
15. Effects of SQ109 on Trichomonas vaginalis. de Souza TG; Granado R; Benaim G; de Souza W; Benchimol M Exp Parasitol; 2023 Jul; 250():108549. PubMed ID: 37196704 [TBL] [Abstract][Full Text] [Related]
16. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report. Tayal S Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518 [TBL] [Abstract][Full Text] [Related]
17. Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity. Muzny CA; Van Gerwen OT; Kissinger P Curr Opin Infect Dis; 2020 Feb; 33(1):73-77. PubMed ID: 31789671 [TBL] [Abstract][Full Text] [Related]
18. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy. Forbes GL; Drayton R; Forbes GD Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945 [TBL] [Abstract][Full Text] [Related]
19. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative. Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567 [TBL] [Abstract][Full Text] [Related]
20. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations. Seña AC; Bachmann LH; Hobbs MM Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]